Literature DB >> 28854340

Sequential analysis and staging of a diethylnitrosamine-induced hepatocellular carcinoma in male Wistar albino rat model.

Abdallah H Fathy1, Mohamed A Bashandy1, Samir A E Bashandy2, Ahmed M Mansour3, Bakheet Elsadek4.   

Abstract

Hepatocellular carcinoma (HCC) is one of the most life-threatening cancers. The present study was designed to chronologically analyze the HCC chemically induced by diethylnitrosamine (DEN) in male Wistar rats during a 27-week period. DEN was given to rats in drinking water (100 mg/L) to induce HCC. In the present study, the DEN-administered groups recorded dramatic results in the tumor markers, oxidative stress, lipid profile, liver function, and hematological parameters at all intervals when compared with their corresponding values in the control groups. In addition, the morphometric analysis of livers of the DEN-administered groups (from 9 to 27 weeks) showed gradual enlargement and several grayish white nodules and foci on the peripheral surface of the liver as the features of HCC. In conclusion, the present sequential model chronologically analyzes all steps of hepatocarcinogenesis and presents a new staging system for classification of HCC that may be valuable for investigating the effects of anticarcinogenic compounds at varying stages of hepatocarcinogenesis in vivo.

Entities:  

Keywords:  DEN; hematology; hepatocarcinogenesis; hématologie; hépatocarcinogenèse; lipid profile; marqueurs tumoraux; oxidative stress; profil lipidique; staging system; stress oxydatif; système de stadification; tumor markers

Mesh:

Substances:

Year:  2017        PMID: 28854340     DOI: 10.1139/cjpp-2017-0413

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  5 in total

Review 1.  Recent Advances in Molecular Mechanisms of the NKG2D Pathway in Hepatocellular Carcinoma.

Authors:  Jian Wang; Cun-Di Li; Lin Sun
Journal:  Biomolecules       Date:  2020-02-14

2.  Hydrocortisone Suppresses Early Paraneoplastic Inflammation And Angiogenesis To Attenuate Early Hepatocellular Carcinoma Progression In Rats.

Authors:  Xiaolong Liu; Haiyan Cui; Hongling Niu; Liping Wang; Xiangzhi Li; Jingbo Sun; Qingzhu Wei; Jianghui Dong; Lixin Liu; Cory J Xian
Journal:  Onco Targets Ther       Date:  2019-11-08       Impact factor: 4.147

3.  Polysaccharide-Rich Fractions from Ganoderma resinaceum (Ganodermataceae) as Chemopreventive Agents in N-Diethylnitrosamine-Induced Hepatocellular Carcinoma in Wistar Rats.

Authors:  Marius Trésor Kemegne Sipping; Francine Kengne Mediesse; Larissa V Kenmogne; Judith Emery Ngomoyogoli Kanemoto; Dieudonné Njamen; Thaddée Boudjeko
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-12       Impact factor: 2.650

4.  Cryptolepine inhibits hepatocellular carcinoma growth through inhibiting interleukin-6/STAT3 signalling.

Authors:  Seth A Domfeh; Patrick W Narkwa; Osbourne Quaye; Kwadwo A Kusi; Gordon A Awandare; Charles Ansah; Alimatu Salam; Mohamed Mutocheluh
Journal:  BMC Complement Med Ther       Date:  2021-06-02

5.  The Therapeutic Effect of Myrrh (Commiphora molmol) and Doxorubicin on Diethylnitrosamine Induced Hepatocarcinogenesis in Male Albino Rats.

Authors:  Hend Mohamed Anwar; Asmaa M Moghazy; Amany Abd Elhameid Osman; Amina A S Abdel Rahman
Journal:  Asian Pac J Cancer Prev       Date:  2021-07-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.